There is general agreement that patients with resectable duodenal cancer achieve better survival than patients with unresectable tumors. Our current resectability rate was 67%, with reported resectability rates ranging from 43% to 87%.
There is general agreement that patients with resectable duodenal adenocarcinomas achieve better survival times than those with unresectable tu- mors.1,15â€“18 In the present study, the resectability rate was 57.1%; other reported resectability rates ranged from 43% to 87%.1,2,8,13,15,17,19 The survival figures for.
The 5-year survival rate tells you what percent of people live at least 5 years after the cancer is found. Percent means how many out of 100. The 5-year survival .
Duodenal adenocarcinoma is a rare cancer, contributing <10 % of. The 5-year survival rates for curative and noncurative resections were 46.4% and 0%, .
Only limited information is available on the incidence, prognosis, and role of. All the tumors were located in the duodenum or proximal jejunum, and all the. . diagnosis was 49 years and the 5- and 10-year survival rates were 44% and 33%